483
Resonance Laboratories Private LimitedFDA 483 - Resonance Laboratories Private Limited - February 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Resonance Laboratories Private Limited in Bengaluru, India, an API manufacturer, revealed significant deficiencies across multiple areas. Observations included inadequate cleaning and sanitization procedures, incomplete batch production records, and insufficient process validation. Additionally, the firm was cited for unvalidated analytical methods, deficient drug substance specifications, and a lack of appropriate personnel training.
Open in Dashboard
ID · 82f789b8-a570-42f4-84fa-43cbf928108e